These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. COVID-19-associated coagulopathy and disseminated intravascular coagulation. Asakura H; Ogawa H Int J Hematol; 2021 Jan; 113(1):45-57. PubMed ID: 33161508 [TBL] [Abstract][Full Text] [Related]
7. Prevention and treatment of COVID-19-associated hypercoagulability: Recommendations of the Algerian society of transfusion and hemobiology. Chekkal M; Deba T; Hadjali S; Lamara H; Oulaa H; Zouai K; Hariti G Transfus Clin Biol; 2020 Nov; 27(4):203-206. PubMed ID: 33022374 [TBL] [Abstract][Full Text] [Related]
8. Maintaining Hemostasis and Preventing Thrombosis in Coronavirus Disease 2019 (COVID-19): Part II. Favaloro EJ; Lippi G Semin Thromb Hemost; 2021 Jun; 47(4):333-337. PubMed ID: 34062596 [No Abstract] [Full Text] [Related]
10. Potential mechanisms of nafamostat therapy for severe COVID-19 pneumonia with disseminated intravascular coagulation. Takahashi W; Yoneda T; Koba H; Ueda T; Tsuji N; Ogawa H; Asakura H Int J Infect Dis; 2021 Jan; 102():529-531. PubMed ID: 33157292 [TBL] [Abstract][Full Text] [Related]
11. COVID-19 versus HIT hypercoagulability. Warkentin TE; Kaatz S Thromb Res; 2020 Dec; 196():38-51. PubMed ID: 32841919 [TBL] [Abstract][Full Text] [Related]
12. Diagnosis and treatment of disseminated intravascular coagulation in COVID-19 patients: a scoping review. Mori H; Ohkawara H; Togawa R; Rikimaru M; Shibata Y; Ikezoe T Int J Hematol; 2021 Mar; 113(3):320-329. PubMed ID: 33550533 [TBL] [Abstract][Full Text] [Related]
13. Diagnosis and management of sepsis-induced coagulopathy and disseminated intravascular coagulation. Iba T; Levy JH; Warkentin TE; Thachil J; van der Poll T; Levi M; J Thromb Haemost; 2019 Nov; 17(11):1989-1994. PubMed ID: 31410983 [No Abstract] [Full Text] [Related]
14. Coagulation abnormalities and thrombosis in patients with COVID-19. Levi M; Thachil J; Iba T; Levy JH Lancet Haematol; 2020 Jun; 7(6):e438-e440. PubMed ID: 32407672 [No Abstract] [Full Text] [Related]
15. [Peculiarities of blood coagulation disorders in patients with COVID-19]. Evtugina NG; Sannikova SS; Peshkova AD; Safiullina SI; Andrianova IA; Tarasova GR; Khabirova AI; Rumyantsev AG; Ataullakhanov FI; Litvinov RI Ter Arkh; 2021 Nov; 93(11):1255-1263. PubMed ID: 36286646 [TBL] [Abstract][Full Text] [Related]
16. COVID-19: Thrombosis, thromboinflammation, and anticoagulation considerations. Levy JH; Iba T; Olson LB; Corey KM; Ghadimi K; Connors JM Int J Lab Hematol; 2021 Jul; 43 Suppl 1(Suppl 1):29-35. PubMed ID: 34288441 [TBL] [Abstract][Full Text] [Related]
17. Thromboelastography-Guided Management of Anticoagulated COVID-19 Patients to Prevent Hemorrhage. Stillson JE; Bunch CM; Gillespie L; Khan R; Wierman M; Pulvirenti J; Phyu H; Anderson S; Al-Fadhl M; Thomas AV; Kwaan HC; Moore E; Moore H; Walsh MM Semin Thromb Hemost; 2021 Jun; 47(4):442-446. PubMed ID: 33607668 [No Abstract] [Full Text] [Related]
18. A unique tale of COVID-19 induced concomitant overt disseminated intravascular coagulation and acute bilateral pulmonary embolism. Siddiqui SN; Jayasekhar R; Tshering S; Jugjali R; Shanmugavadivel D; Jawed A; Rahman MM Int J Infect Dis; 2021 Mar; 104():568-571. PubMed ID: 33486013 [TBL] [Abstract][Full Text] [Related]